Cargando…
Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
In this randomized, double-blind, placebo-controlled study, we evaluated the efficacy of an individualized technique of subcutaneous injection of botulinum toxin type A (BoNT-A) targeted (SjBoT) to the occipital or trigeminal skin area in non-responder patients with chronic migraine (CM). Patients w...
Autores principales: | Bono, Francesco, Mazza, Maria Rosaria, Magro, Giuseppe, Spano, Giorgio, Idone, Giovanni, Laterza, Vincenzo, Tedeschi, Denise, Pucci, Francesco, Gambardella, Antonio, Sarica, Alessia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224529/ https://www.ncbi.nlm.nih.gov/pubmed/37235358 http://dx.doi.org/10.3390/toxins15050324 |
Ejemplares similares
-
Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
por: Schaefer, Sara M., et al.
Publicado: (2015) -
Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine
por: Valente, Mariarosaria, et al.
Publicado: (2021) -
On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015) -
Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia
por: Sandrini, Giorgio, et al.
Publicado: (2017) -
Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)